The PCR-based point-of-care assays, which return results within 20 minutes, have received regulatory approval from the US Food and Drug Administration earlier this year.

The DNA nanotechnology market is booming, driven by precision medicine and AI integration. Over 1,500 research projects and 300 clinical trials highl ...

The global biosensors market was valued at $26.75 billion in 2022 and is projected to reach $45.95 billion by 2030. This ...

In this review, we summarize recent advances in microfluidic biosensor technology, highlighting innovations in detection techniques such as electrochemical and ... With the growing demand in the field ...

Abstract: The design and optimization of a surface plasmon resonance (SPR) biosensor for very sensitive detection of Mycobacterium tuberculosis is presented in this work. Using the transfer matrix ...

Understanding the strengths and limitations of the different methods can aid in the practical use of miRNA profiling for diverse clinical applications, including the development of a point-of-care ...

Objectives To summarise the literature regarding the use of point-of-care test (POCT) in pharmacies versus control/usual care. Design and setting Systematic review and random-effects meta-analysis in ...

Objective The aim of this review was to collate all available evidence on the impact of point-of-care C reactive protein (CRP) testing on patient-relevant outcomes in children and adults in ambulatory ...

Skin care minimalism is the overarching theme this year according to several of our experts. “The ‘skinimalism’ movement appears to be evolving beyond just using fewer products — consumers ...

Artificial Intelligence (AI) is reshaping the healthcare industry by enhancing medical equipment, improving diagnostic accuracy, and streamlining patient care ... These devices are life savers ...